![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 487/04 | (2006.01) |
C07D 487/04 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 31/496 | (2006.01) | ||
A61K 31/5377 | (2006.01) | ||
A61K 31/4709 | (2006.01) | ||
A61K 31/454 | (2006.01) | ||
A61K 31/4439 | (2006.01) |
(11) | Patento numeris | 3986898 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20734872.3 |
Europos patento paraiškos padavimo data | 2020-06-19 | |
(97) | Europos patento paraiškos paskelbimo data | 2022-04-27 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-15 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2020/067082 |
Data | 2020-06-19 |
(87) | Numeris | WO 2020/254565 |
Data | 2020-12-24 |
(30) | Numeris | Data | Šalis |
19181754 | 2019-06-21 | EP |
(72) |
DOLENTE, Cosimo , CH
GOERGLER, Annick , CH
HEWINGS, David , CH
JAESCHKE, Georg , CH
KUHN, Bernd , CH
NAGEL, Yvonne Alice , CH
OBST SANDER, Ulrike , CH
RICCI, Antonio , CH
RUEHER, Daniel , CH
STEINER, Sandra , CH
|
(73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | EGFR INHIBITORS FOR THE TREATMENT OF CANCER |
EGFR INHIBITORS FOR THE TREATMENT OF CANCER |